360 related articles for article (PubMed ID: 29124520)
1. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
Clin Transl Oncol; 2018 Jan; 20(1):3-15. PubMed ID: 29124520
[TBL] [Abstract][Full Text] [Related]
2. Treatment Strategies for Low-Grade Glioma in Adults.
Oberheim Bush NA; Chang S
J Oncol Pract; 2016 Dec; 12(12):1235-1241. PubMed ID: 27943684
[TBL] [Abstract][Full Text] [Related]
3. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
4. SEOM clinical guidelines for anaplastic gliomas (2017).
Balañá C; Alonso M; Hernandez-Lain A; Hernandez A; Perez-Segura P; Pineda E; Ramos A; Sanchez AR; Teixidor P; Verger E; Benavides M
Clin Transl Oncol; 2018 Jan; 20(1):16-21. PubMed ID: 29058264
[TBL] [Abstract][Full Text] [Related]
5. Current Considerations in the Treatment of Grade 3 Gliomas.
Jo J; Schiff D
Curr Treat Options Oncol; 2022 Sep; 23(9):1219-1232. PubMed ID: 35913658
[TBL] [Abstract][Full Text] [Related]
6. Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.
Buckner J; Giannini C; Eckel-Passow J; Lachance D; Parney I; Laack N; Jenkins R
Nat Rev Neurol; 2017 Jun; 13(6):340-351. PubMed ID: 28497806
[TBL] [Abstract][Full Text] [Related]
7. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
Taylor JW; Chi AS; Cahill DP
Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
[TBL] [Abstract][Full Text] [Related]
8. Foundations of the Diagnosis and Management of Low-Grade Gliomas.
Norman S; Juthani RG; Magge R
World Neurosurg; 2022 Oct; 166():306-312. PubMed ID: 36192862
[TBL] [Abstract][Full Text] [Related]
9. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
10. The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Cahill DP; Sloan AE; Nahed BV; Aldape KD; Louis DN; Ryken TC; Kalkanis SN; Olson JJ
J Neurooncol; 2015 Dec; 125(3):531-49. PubMed ID: 26530263
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.
Walker DG; Kaye AH
Australas Radiol; 2001 Nov; 45(4):472-82. PubMed ID: 11903181
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
Paul Y; Mondal B; Patil V; Somasundaram K
Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
[TBL] [Abstract][Full Text] [Related]
13. [Basic principles of diagnosis and treatment of gliomas].
Wirsching HG; Weiss T; Roth P; Weller M
Nervenarzt; 2018 Jun; 89(6):692-698. PubMed ID: 29679127
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
16. The management of low-grade gliomas in adults.
Morshed RA; Young JS; Hervey-Jumper SL; Berger MS
J Neurosurg Sci; 2019 Aug; 63(4):450-457. PubMed ID: 30916536
[TBL] [Abstract][Full Text] [Related]
17. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura PP; Quintela NV; García MM; Del Barco Berrón S; Sarrió RG; Gómez JG; Castaño AG; Martín LMN; Rubio OG; Losada EP
Clin Transl Oncol; 2023 Sep; 25(9):2634-2646. PubMed ID: 37540408
[TBL] [Abstract][Full Text] [Related]
18. Adult-type Diffuse Gliomas.
de la Fuente MI
Continuum (Minneap Minn); 2023 Dec; 29(6):1662-1679. PubMed ID: 38085893
[TBL] [Abstract][Full Text] [Related]
19. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C
J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377
[TBL] [Abstract][Full Text] [Related]
20. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
